Eli Lilly (LLY) Inventory Average (2009 - 2026)

Eli Lilly has reported Inventory Average for 18 years, with the latest figure at $14.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 67.3% year-over-year to $14.1 billion; the trailing twelve-month figure through Mar 2026 stood at $14.1 billion (up 67.3% YoY), and the FY2025 full-year result was $10.7 billion, up 59.66% from the prior year.
• Inventory Average for Q1 2026 stood at $14.1 billion, up from $13.0 billion in the prior quarter.
• The five-year high for Inventory Average was $14.1 billion in Q1 2026, with the low at $3.9 billion in Q3 2022.
• Historically, Inventory Average has averaged $7.0 billion across 5 years, with a median of $5.9 billion in 2024.
• Annual changes were most pronounced in 2022 — Inventory Average decreased 0.02% — and 2025, when it soared 72.27%.
• Eli Lilly's Inventory Average stood at $4.1 billion in 2022, then surged by 31.12% to $5.3 billion in 2023, then surged by 40.98% to $7.5 billion in 2024, then jumped by 72.27% to $13.0 billion in 2025, then increased by 9.06% to $14.1 billion in 2026.
• The last three Inventory Average figures came in at $14.1 billion (Q1 2026), $13.0 billion (Q4 2025), and $11.6 billion (Q3 2025), per Business Quant data.